- Home
- Plastic Surgery
- Aesthetic Surgery
- augmentation mammoplasty
- Breast implant removals
- Mastopexy
- Buttock lift
- Jaw reshaping
- Dermabrasion
- Blepharoplasty
- Rhytidectomy
- Forehead lift
- Hair Transplantation
- Lip augmentation
- Lipoplasty
- Lower body lift
- Rhinoplasty
- Thigh lift
- Abdominoplasty
- Brachioplasty
- Botox injections
- Cellulite treatment
- Chemical peel
- Facial rejuvenation
- Laser skin resurfacing
- Laser treatment of leg veins
- Vaginal rejuvenation
- Aesthetic Surgery
- Dentistry (Odontology)
- More Topics (Coming Soon)
Subscribe to Updates
Browsing: Clinical
The relationship between periodontitis and diabetes has similarly been explained by dysfunctions of the immune response.12-14 Diabetics, especially those with severe periodontitis, have been found to…
Investigational Nonopioid VX-548 Reduces Moderate to Severe Postoperative Pain in Late-Stage Clinical Trials
In 2 pivotal phase 3 randomized clinical trials, the investigational selective NaVThe 1,8-blocker was associated with a statistically significant improvement in pain intensity and a clinically…
image: Dr. Avinash Bidra is the lead author of the first national clinical practice guidelines published by the American College of Prosthodontists calling for lifelong maintenance…
Acclaro Corporation Highlights Clinical Study Results of UltraClear™ Cold Ablative Fiber Laser for Skin Resurfacing at American Laser Society for Medicine and Surgery 2023 Annual Conference
~ Podium presentations and showcase of device demonstrations UltraClear’s versatile platform of four different treatment modalities for skin regeneration – from facial rejuvenation and scar resurfacing…
Teikoku Pharma USA announces positive results from Phase 2 clinical trial of TPU-006, a non-opioid pain management patch in abdominoplasty. USA – English India – English
SAN JOSE, September 6, 2023 /PRNewswire/ — Teikoku Pharma USA, a global pharmaceutical company, today announced positive results from its Phase 2 proof-of-concept study of TPU-006,…
Teikoku Pharma USA announces positive results from Phase 2 clinical trial of TPU-006, a non-opioid pain management patch in abdominoplasty.
SAN JOSE, September 6, 2023 /CNW/ — Teikoku Pharma USA, a global pharmaceutical company, today announced positive results from its Phase 2 proof-of-concept study of TPU-006,…
Periodontitis is a chronic disease not uncommon in dentistry. Typically, non-surgical periodontal treatments are the first line of treatment for the diagnosis of periodontitis. If the…